Page last updated: 2024-08-21

chenodeoxycholic acid and Cancer of Endometrium

chenodeoxycholic acid has been researched along with Cancer of Endometrium in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Andò, S; Avena, P; Casaburi, I; Catalano, S; Giordano, F; Lanzino, M; Maris, P; Morelli, C; Sisci, D1
Akerlund, M; Breeze, A; Filipowska, D; Filipowski, T; Kazanowska, W; Lapinjoki, S; Laudanski, T; Morelowska, B1

Trials

1 trial(s) available for chenodeoxycholic acid and Cancer of Endometrium

ArticleYear
Treatment of cancer patients with a low-density-lipoprotein delivery vehicle containing a cytotoxic drug.
    Cancer chemotherapy and pharmacology, 1992, Volume: 29, Issue:5

    Topics: Adenocarcinoma; Adrenal Cortex; Chenodeoxycholic Acid; Cystadenocarcinoma; Drug Carriers; Drug Therapy, Combination; Endometrial Neoplasms; Female; Humans; Lipoproteins, LDL; Liver; Ovarian Neoplasms; Prednisolone; Time Factors; Vincristine

1992

Other Studies

1 other study(ies) available for chenodeoxycholic acid and Cancer of Endometrium

ArticleYear
Chenodeoxycholic acid through a TGR5-dependent CREB signaling activation enhances cyclin D1 expression and promotes human endometrial cancer cell proliferation.
    Cell cycle (Georgetown, Tex.), 2012, Jul-15, Volume: 11, Issue:14

    Topics: Cell Line, Tumor; Cell Proliferation; Chenodeoxycholic Acid; Cyclic AMP Response Element-Binding Protein; Cyclin D1; Endometrial Neoplasms; Female; Gastrointestinal Agents; Humans; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mutagenesis, Site-Directed; Promoter Regions, Genetic; Receptors, G-Protein-Coupled; RNA Interference; RNA, Small Interfering; Signal Transduction; Up-Regulation

2012